Carine L. Dos Santos
Uberlandia, MG 38405317, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Quercetin Reduces Toxoplasma gondii Infection in In Vitro and Ex Vivo Placental Models.
Journal: International journal of molecular sciences
Published: May 21, 2026
Anti-Toxoplasma gondii activity of two novel synthetic compounds based on pyridine, benzimidazole and benzoxazole scaffolds in human maternal-fetal interface models.
Journal: Microbial pathogenesis
Published: April 14, 2026
Brazilian Red Propolis and Its Active Constituent 7-O-methylvestitol Impair Early and Late Stages of Toxoplasma gondii Infection in Human Placental Models.
Journal: Microorganisms
Published: June 30, 2025
BthTX-II, an Asp49 PLA2 from Bothrops jararacussu, Impairs Toxoplasma gondii Infection: In Vitro and Ex Vivo Approaches.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 27, 2025
Trypanosoma cruzi Growth Is Impaired by Oleoresin and Leaf Hydroalcoholic Extract from Copaifera multijuga in Human Trophoblast and Placental Explants.
Journal: Pathogens (Basel, Switzerland)
Published: June 16, 2025
Galectin-3 plays a key role in controlling infection by Toxoplasma gondii in human trophoblast cells and human villous explants.
Journal: Frontiers in cellular and infection microbiology
Published: July 04, 2024
Copaifera spp. oleoresins control Trypanosoma cruzi infection in human trophoblast cells (BeWo) and placental explants.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 11, 2024
Antioxidant and anti-Alzheimer's potential of Tetragonisca angustula (Jataí) stingless bee pollen.
Journal: Scientific reports
Published: July 07, 2023
Trypanosoma cruzi P21 recombinant protein modulates Toxoplasma gondii infection in different experimental models of the human maternal-fetal interface.
Journal: Frontiers in immunology
Published: June 21, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026